<DOC>
	<DOCNO>NCT01113047</DOCNO>
	<brief_summary>This study ass efficacy safety single pill combination Aliskiren Amlodipine patient moderate hypertension adequately respond single pill combination Olmesartan Amlodipine . Further study also assess efficacy safety single pill combination Aliskiren , Amlodipine Hydrochlorothiazide ( HCTZ ) patient moderate hypertension adequately respond single pill combination Aliskiren Amlodipine .</brief_summary>
	<brief_title>Aliskiren Combination With Amlodipine Hypertensive Patients Not Responding Angiotensin Receptor Blocker ( ARB ) Plus Amlodipine</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Essential hypertension stage II Male female patient Age &gt; = 18 year old Severe hypertension ( systolic BP &gt; = 180 mmHg , diastolic BP &gt; = 110 mmHg Poorly control diabetes mellitus type 1 DM History myocardial infarction , stroke Presence heart failure Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Aliskiren</keyword>
	<keyword>Amlodipine</keyword>
</DOC>